Position in NTRA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$8,929,553
+$7,084,692 QoQ
Shares Held
44,650
+454.5% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026CenterBook Partners LP holds $15,514,534 across 7 Diagnostics & Research names. NTRA ranks #1 (57.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
This page
|
44,650 | $8,929,553 | |
| 2 | SHC |
Sotera Health Co
|
146,855 | $2,105,900 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
3,740 | $1,838,322 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
7,416 | $1,264,724 | |
| 5 | ICLR |
Icon PLC
|
5,394 | $596,900 | |
| 6 | DHR |
Danaher Corp /De/
|
2,810 | $532,776 | |
| 7 | RVTY |
Revvity, Inc.
|
2,812 | $246,359 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,929,553 | 44,650 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,844,861 | 8,053 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,423,884 | 33,695 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $6,279,330 | 37,169 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $14,412,790 | 101,922 | Shares | Sole | 2025-05-09 | |
| 2024-09-30 | $6,792,840 | 53,508 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,250,015 | 66,950 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||